Fresenius Medical Care AG (ETR:FME)
Germany
· Delayed Price · Currency is EUR 46.85
-0.33 (-0.70%)
Jul 9, 2025, 5:35 PM CET
Fresenius Medical Care AG Revenue
Fresenius Medical Care AG had revenue of 4.88B EUR in the quarter ending March 31, 2025, with 3.32% growth. This brings the company's revenue in the last twelve months to 19.49B, up 0.10% year-over-year. In the year 2024, Fresenius Medical Care AG had annual revenue of 19.34B, down -0.61%.
Revenue (ttm)
19.49B
Revenue Growth
+0.10%
P/S Ratio
0.71
Revenue / Employee
173.99K
Employees
111,513
Market Cap
13.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 19.34B | -117.71M | -0.61% |
| Dec 31, 2023 | 19.45B | 55.60M | 0.29% |
| Dec 31, 2022 | 19.40B | 1.78B | 10.10% |
| Dec 31, 2021 | 17.62B | -240.38M | -1.35% |
| Dec 31, 2020 | 17.86B | 382.51M | 2.19% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Siemens Healthineers AG | 23.14B |
| Merck KGaA | 21.32B |
| Bayer Aktiengesellschaft | 46.58B |
| Fresenius SE & Co. KGaA | 22.13B |
| Sartorius Aktiengesellschaft | 3.44B |
| Fielmann Group AG | 2.33B |
| Carl Zeiss Meditec AG | 2.17B |
| SCHOTT Pharma AG & Co. KGaA | 972.81M |
Fresenius Medical Care AG News
- 6 days ago - Fresenius Medical in-pact with Coordination of National Institutes in Mexico - Seeking Alpha
- 6 days ago - Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico - PRNewsWire
- 22 days ago - Fresenius Medical Care initiates €1B share buyback - Seeking Alpha
- 22 days ago - Fresenius Medical Care Launches Value-Based Care Segment, Eyes Growth Through Innovation, Efficiency - Benzinga
- 22 days ago - Fresenius Medical Care Launches Value-Based Care Segment, Eyes Growth Through Innovation, Efficiency - Benzinga
- 22 days ago - Fresenius Medical Care CEO Says Company Could Benefit From Obesity Drugs - WSJ
- 22 days ago - Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation - PRNewsWire
- 22 days ago - Fresenius Medical Care announces 1 bln euros share buyback programme - Reuters